Literature DB >> 3137320

Effect of early low-volume enteral substrate on subsequent feeding tolerance in very low birth weight infants.

T A Slagle1, S J Gross.   

Abstract

To determine the effect of small enteral feedings on small bowel function, 46 infants with birth weight less than 1500 g, selected on the basis of risk factors for feeding intolerance, were assigned randomly to one of two feeding groups. Group 1 received low-volume enteral feeds (12 ml/kg/day) in addition to parenteral alimentation for 10 days beginning on day 8 of life; group 2 received parenteral alimentation alone until day 18 of life. After this trial period feedings were increased by 15 ml/kg/day in all infants. Four infants (9%) developed necrotizing enterocolitis (one prior to any feeds, two in group 1, and one in group 2); two others were dropped from the study for reasons unrelated to feeding. The remaining 18 infants in group 1 had improved feeding tolerance compared with the 22 in group 2, as manifested by fewer days that gastric residuum totalled more than 10% of feedings (1.3 +/- 0.5 days vs 3.2 +/- 0.6 days, respectively, p less than 0.05) and fewer days that feedings were discontinued because of feeding intolerance (2.7 +/- 0.8 days vs 5.5 +/- 0.9 days, respectively, p less than 0.05). Consequently, 17 of 18 (94%) infants who had received the early low-volume enteral feedings achieved an enteral intake of 120 kcal/kg/day by 6 weeks of life, whereas only 14 of 22 (64%) infants in the delayed feeding group reached this intake (p less than 0.05). Peak total serum bilirubin concentrations were comparable in the two groups. The initiation of hypocaloric enteral substrate as an adjunct to parenteral nutrition improved subsequent feeding tolerance in sick infants with very low birth weight.

Entities:  

Mesh:

Year:  1988        PMID: 3137320     DOI: 10.1016/s0022-3476(88)80646-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

Review 1.  Feeding issues in preterm infants.

Authors:  R J Cooke; N D Embleton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

2.  Randomised controlled trial of trophic feeding and gut motility.

Authors:  R J McClure; S J Newell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

Review 3.  Hepatobiliary abnormalities and parenteral nutrition.

Authors:  B S Tomar
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

4.  Minimal enteral feeding, fetal blood flow pulsatility, and postnatal intestinal permeability in preterm infants with intrauterine growth retardation.

Authors:  R M van Elburg; A van den Berg; C M Bunkers; R A van Lingen; E W A Smink; J van Eyck; W P F Fetter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

5.  Randomised controlled study of clinical outcome following trophic feeding.

Authors:  R J McClure; S J Newell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

6.  Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants.

Authors:  D C Wilson; P Cairns; H L Halliday; M Reid; G McClure; J A Dodge
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

7.  EXTREMELY LOW BIRTH WEIGHT BABIES.

Authors:  T S Raghuraman
Journal:  Med J Armed Forces India       Date:  2017-06-10

Review 8.  Necrotizing enterocolitis: Pathophysiology from a historical context.

Authors:  David Hackam; Michael Caplan
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

Review 9.  Necrotizing enterocolitis: a practical guide to its prevention and management.

Authors:  Pinaki Panigrahi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

10.  ADEPT - Abnormal Doppler Enteral Prescription Trial.

Authors:  Alison Leaf; Jon Dorling; Steve Kempley; Kenny McCormick; Paul Mannix; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2009-10-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.